Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-Exposure Prophylaxis to Prevent HIV Acquisition in US Women
NCT03058835Phase 4Completed
- Sponsor
- Rutgers University
- Start
- Sep 2016
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tenofovir disoproxil fumarate, emtricitabine in human immunodeficiency virus infection (HIV), sponsored by Rutgers University. Started Sep 2016; status: completed.
02
Drugs
tenofovir disoproxil fumarateemtricitabine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT03058835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03058835.